The long-awaited US Food and Drug Administration guidance on social media for drug companies has arrived, and it includes information on how to discuss the risks and benefits of drugs on a social media platform like Twitter and how to correct misinformation present on websites like Wikipedia, Pharmalot's Ed Silverman writes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Guideline Change

Sorta Safe and Secure

Put It in the Jar

CRO Future

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.